Symposium on molecular pathogenesis of respiratory diseases and its clinical implication. 3. Immunological lung disease--recent advances in the pathogenesis of hypersensitivity pneumonitis.
Yoshizawa
Y
Y
Tokyo Medical and Dental University, The Pulmonary Medicine.
Furuie
T
T
Otani
Y
Y
Sumi
Y
Y
Sawada
M
M
Umino
T
T
Inase
N
N
Miyake
S
S
D000485:Allergens / Q000009:adverse effects / Q000737:chemistry / Q000302:isolation & purification; D000542:Alveolitis, Extrinsic Allergic / Q000209:etiology* / Q000276:immunology; D000818:Animals; D000946:Antigens, Fungal / Q000009:adverse effects / Q000737:chemistry / Q000302:isolation & purification; D001716:Bird Fancier's Lung / Q000209:etiology / Q000276:immunology; D016207:Cytokines / Q000502:physiology; D004797:Enzyme-Linked Immunosorbent Assay; D000939:Epitopes / Q000276:immunology; D005203:Farmer's Lung / Q000209:etiology / Q000276:immunology; D006801:Humans; D051379:Mice; D008809:Mice, Inbred C3H; D008810:Mice, Inbred C57BL; D023421:Models, Animal; D008954:Models, Biological; D011134:Polysaccharides / Q000009:adverse effects / Q000737:chemistry / Q000302:isolation & purification; D012621:Seasons; D018418:Th2 Cells / Q000276:immunology; D014250:Trichosporon / Q000276:immunology
D000485:Allergens; D000946:Antigens, Fungal; D016207:Cytokines; D000939:Epitopes; D011134:Polysaccharides; C027478:glucuronoxylomannan